Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
5
×
Tags
biotech
boston
5
×
boston blog main
cancer
5
×
national blog main
national top stories
5
×
boston top stories
life sciences
new york blog main
foundation medicine
genentech
roche
san francisco blog main
startups
adeno-associated virus
australia
avapritinib
beam therapeutics
bill mckeon
biotech week boston
blueprint medicines
bristol-myers squibb
broad institute
bwb
cancer drugs
cancer immunotherapy
capmatinib
center for medicare and medicaid services
chemotherapy
cindy perettie
cisplatin
clinical trials
commercialization
companion diagnostic
crispr
daniel o'day
david liu
deals
decibel therapeutics
drugs
What
medicine
medicines
acquire
adding
address
ago
agreed
aiming
announced
approval
approves
balance
benefiting
big
billion
blueprint
boston
broad
build
cancer
carries
center
center’s
certain
coming
confidence
decibel
designed
diagnostics
didn’t
director
drug
drugs
emerged
fda
focus
forms
foundation
gain
genentech
Language
unset
Current search:
photo
×
boston
×
" national top stories "
×
cancer
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
@xconomy.com
5 years ago
Laurie Glimcher To Headline Xconomy Keynote Series in Boston in September
@xconomy.com
5 years ago
JLabs’ Luby Takes the Reins at TMC Innovation Institute in Houston
@xconomy.com
5 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine